Priorities for developing countries in the global response to non-communicable diseases

Globalization and Health

Volumn 8, Issue , 2012, Pages

  Maher, Dermot ^a   Ford, Nathan ^b,c   Unwin, Nigel ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Non communicable diseases; Prevention; Treatment

Indexed keywords

ACTION PLAN; DEVELOPING WORLD; DISEASE CONTROL; DISEASE TREATMENT; EPIDEMIOLOGY; FINANCIAL PROVISION; HEALTH POLICY; HEALTH RISK; HEALTH SERVICES; MORTALITY; PRIORITIZATION; PUBLIC HEALTH; RESEARCH AND DEVELOPMENT; RISK FACTOR;

ARTICLE; DEVELOPING COUNTRY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASES; FUNDING; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; MORTALITY; NON COMMUNICABLE DISEASE; POLITICS; PREVENTION AND CONTROL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; TREATMENT PLANNING; CHRONIC DISEASE; HEALTH CARE PLANNING; TRANSLATIONAL RESEARCH;

CHRONIC DISEASE; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HEALTH PRIORITIES; HUMANS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84861976226     PISSN: None     EISSN: 17448603     Source Type: Journal    
DOI: 10.1186/1744-8603-8-14     Document Type: Article

References (55)

1. World Health Organization Global infobase https://apps.who.int/infobase/mortality.aspx2, World Health Organization.
2. World Health Organization Global status report on non-communicable diseases 2010, http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf, World Health Organization.
3. Geneau R, Stuckler D, Stachenco S. Raising the priority of preventing chronic diseases: a political process. Lancet 2010, 376:1689-1698.
4. Suhrcke M, Nugent RA, Stuckler D, Rocco L. Chronic disease: an economic perspective 2006, Oxford Health Alliance, London.
5. Adeyi O, Smith O, Robles S. Public policy and the challenge of chronic non-communicable diseases 2002, World Bank, Washington, DC.
6. General Assembly of the United Nations High-level Meeting on Non-communicable Diseases http://www.un.org/en/ga/president/65/issues/ncdiseases.shtml, General Assembly of the United Nations.
7. Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save?. Lancet 2005, 366:1578-1582.
8. Narayan KMV, Zhang P, Kanaya AM, et al. Diabetes: the pandemic and potential solutions. Disease control priorities in developing countries 2006, Washington, DC, The World Bank, Jamison DT, Breman JG, Measham AR, 2.
9. Gaziano TA, Reddy KS, Paccaud F, Horton S, Chaturvedi V. Cardiovascular disease. Disease control priorities in developing countries 2006, Washington, DC, The World Bank, Jamison DT, Breman JG, Measham AR, 2.
10. Lim SS, Gaziano TA, Gakidou E, et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007, 370:2054-2062.
11. World Health Organization 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases 2008, WHO, Geneva, World Health Organization.
12. World Health Organization Sixty-fourth World Health Assembly. Document A64/21 2011, WHO, Geneva, World Health Organization.
13. Maher D, Harries A, Zachariah R, Enarson D. A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Publ Health 2009, 9:355.
14. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010, 376:1186-1193.
15. First Global Ministerial Conference on NCDs and Healthy Lifestyles 2011, http://www.who.int/nmh/events/moscow_ncds_2011/en/.
16. Piot P, Ebrahim S. Prevention and control of chronic diseases. Br Med J 2010, 342:293-294.
17. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet 2011, 377:1438-1447.
18. General Assembly of the United Nations High-level Meeting on AIDS 2006, http://www.un.org/ga/aidsmeeting2006, General Assembly of the United Nations.
19. Maher D. Implications of the global financial crisis for the response to diseases of poverty within overall health sector development: the case of tuberculosis. Trop Med Int Health 2010, 15(1):11-17.
20. Maher D, von Schoen-Angerer T, Cohn J. Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection. Int J Clin Pract 2011, 65:824-827.
21. Bemelmans M, van de Akker T, Ford N, Philips M, Zachariah R, Harries A, Schouten E, Hermann K, Mwagomba B, Massaquoi M. Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health 2010, 12:1413-1420.
22. Wilkinson D, Wilkinson NF. Organisation of non-communicable disease care. Principles of medicine in Africa 2004, Cambridge University Press, Cambridge, Parry E, Godfrey R, Mabey D, Gill G, 3.
23. Maher D. Re-thinking global health sector efforts for HIV and tuberculosis epidemic control: promoting integration of programme activities within a strengthened health system. BMC Publ Health 2010, 10:394.
24. Allotey P, Reidpath DD, Yasin S, Chan CK, Aikins AD. Rethinking health-care systems: a focus on chronicity. Lancet 2011, 377:450-451.
25. Rawaf S, De Maeseneer J, Starfield B. From Alma-Ata to Almaty: a new start for primary health care. Lancet 2008, 372:1365-1367.
26. World Health Organization The world health report 2008: primary health care, now more than ever 2008, WHO, Geneva, World Health Organization.
27. Jha P. Control of non-communicable diseases in sub-Saharan Africa Disease Control Priorities Project.http://www.dcp2.org/file/203/djcc_jha.pdf.
28. Maher D, Smeeth L, Sekajugo J. Health transition in Africa: practical policy proposals for primary care. Bull World Health Organ 2010, 88:943-948.
29. Maher D, Harries AD. Quality care: a link between clinical and public health approaches to HIV infection in developing countries. Trop Med Int Health 2010, 15(4):391-395.
30. Maher D. Tuberculosis control: good clinical care and good public health. Tuberculosis handbook 2008, Mannheim, Germany, Wiley-VCH, Kaufmann S, Rubin E, Britton W, Helden P.
31. World Health Organization Antiretroviral therapy for HIV infection in adults and adolescents 2010, WHO, Geneva, http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf, World Health Organization.
32. Maher D. Standardised interventions in international health: Procrustes, where are you now?. Trop Med Int Health 2009, 14(11):1-3.
33. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, de Cock K. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006, 368:505-510.
34. World Health Organization Global tuberculosis control: WHO Report 2010 2010, WHO, Geneva, http://whqlibdoc.who.int/publications/2010/9789241564069_eng.pdf, World Health Organization.
35. World Health Organization Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2010 2010, http://www.who.int/hiv/pub/2010progressreport/en/, World Health Organization.
36. Joint United Nations Programme on HIV/AIDS Chronic care for HIV and non-communicable diseases. How to leverage the HIV experience 2011, UNAIDS, Geneva, http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/20110526_JC2145_Chronic_care_of_HIV.pdf, Joint United Nations Programme on HIV/AIDS.
37. Maher D, Sekajugo J, Harries AD, Grosskurth H. Research needs for an improved primary care response to chronic non-communicable diseases in Africa. Tropical Medicine and International Health 2010, 15(2):176-181.
38. Young F, Critchley JA, Johnstone LK, Unwin NC. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health 2009, 5:9. 10.1186/1744-8603-5-9 PMID:19751503.
39. Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 2007, 85:279-288.
40. Ait-Khaled N, Auregan G, Bencharif N, Mady Carmara L, Dagli E, Djankine K, Keita B, Ky C, Mahi S, Ngoran K, Pham DL, Sow O, Yousser M, Zidouni N, Enarson DA. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int J Tuberc Lung Dis 2000, 4:268-271.
41. Asthma Drugs Facility http://www.globaladf.org/, Asthma Drugs Facility.
42. Global Drug Facility for anti-tuberculosis drugs http://www.stoptb.org/gdf/.
43. Ford N, Calmy A, Mills E. The first decade of antiretroviral therapy in Africa. Glob Heal 2011, 7:33.
44. Ford N, Roberts T, Calmy A. Viral load monitoring in resource-limited settings: a medical and public health priority. AIDS 2012, [in press].
45. Zachariah R, Ford N, Maher D, Bissel K, van Den Bergh R, van Den Boogaard W, et al. Is operational research delivering the goods? Assessing the journey from generating evidence to policy and practice change in low-income countries?. Lancet Infect Dis 2012, 12:415-421.
46. The global alliance for chronic diseases. Lancet 2009, 373:2084.
47. Maher D, Sekajugo J. Research on health transition in Africa: time for action. Health Research, Policy and Systems 2011, 9:5.
48. Maher D, Waswa L, Baisley K, Karabarinde A, Unwin N, Grosskurth H. Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda. Int J Epidemiol 2010, 1-12.
49. Maher D, Waswa L, Baisley K, Karabarinde A, Unwin N. Epidemiology of hypertension in low-income countries: a cross-sectional population-based survey in rural Uganda. J Hypertens 2011, 29:1061-1068.
50. World Bank World development report 1993: investing in health 1993, Oxford University Press, New York, World Bank.
51. Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011, early online publication.
52. World Health Organization The world health report 2004: changing history 2004, WHO, Geneva, World Health Organization.
53. Nugent RA, Yach D, Feigl AB. Noncommunicable diseases and the Paris Declaration. Lancet 2009, 374:784-785.
54. Ooms G, Van Damme W, Baker BK, Zeitz P, Schrecker T. The 'diagonal' approach to Global Fund financing: a cure for the broader malaise of health systems?. Global Health 2008, 4:6.
55. Mills EJ, Ford N. Political lessons from the global HIV/AIDS response to inform a rapid non-communicable disease response. AIDS 2012, 26:1171-1173.